Global Breathing Disorders & Treatment Market Size By Type (Asthma, COPD), By Application (Hospital, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Breathing Disorders & Treatment Market was valued at USD 18.2 billion in 2023 and is projected to reach USD 31.7 billion by 2031, growing at a CAGR of 6.9% during the forecast period of 2023-2031. The market's expansion is driven by the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and lung infections. Technological advancements in respiratory care devices, rising pollution levels, growing geriatric population, and the surging demand for home healthcare solutions are contributing to the growth of this market.

Breathing disorders impact millions globally, necessitating efficient diagnosis, treatment, and management strategies. The development of innovative respiratory therapies, portable oxygen concentrators, and non-invasive ventilation devices is expected to further accelerate market growth.

Drivers:

Increasing Prevalence of Respiratory Diseases:

The rising incidence of asthma, COPD, and sleep apnea is a key driver. Urbanization, smoking habits, occupational hazards, and air pollution exacerbate the burden of respiratory disorders globally.

Technological Advancements in Treatment Devices:

Continuous innovation in respiratory monitoring devices, smart inhalers, portable ventilators, and oxygen concentrators enhances patient compliance and offers better disease management, driving market adoption.

Growing Demand for Home Healthcare:

Home-based respiratory care is gaining traction due to the convenience and reduced hospital visits it offers, especially post-COVID-19, fostering market growth.

Restraints:

High Cost of Advanced Respiratory Devices:

The expensive nature of technologically advanced devices, especially in developing regions, can limit accessibility and market penetration.

Stringent Regulatory Approvals:

Stringent regulatory frameworks and compliance requirements for new respiratory devices can delay product launches and restrict market growth.

Opportunity:

Rising Adoption of Telemedicine and Remote Monitoring:

Remote monitoring of respiratory patients through connected devices and telemedicine platforms presents significant growth opportunities for healthcare providers and device manufacturers.

Expansion in Emerging Markets:

Increasing healthcare investments, growing awareness of respiratory health, and improving healthcare infrastructure in Asia-Pacific, Latin America, and Middle East & Africa offer lucrative market prospects.

Market by System Type Insights:

Based on system type, the Therapeutic Devices segment accounted for the largest market share in 2023. Devices such as inhalers, nebulizers, and ventilators remain integral in treating breathing disorders. The Monitoring Devices segment is expected to witness the highest growth during the forecast period, driven by the growing trend of remote patient monitoring and wearable respiratory devices.

Market by End-use Insights:

Hospitals & Clinics emerged as the largest end-use segment in 2023, attributed to the rising number of hospitalizations for severe respiratory conditions. However, the Homecare Settings segment is poised to register the fastest growth rate during the forecast period due to increasing patient preference for at-home treatment options and technological advancements in portable respiratory devices.

Market by Regional Insights:

North America dominated the Global Breathing Disorders & Treatment Market in 2023, owing to the region's advanced healthcare infrastructure, high prevalence of respiratory diseases, and favorable reimbursement policies. Asia-Pacific is projected to witness the highest growth rate during 2023-2031, supported by increasing healthcare expenditure, rapid urbanization, and rising pollution levels in emerging economies like China and India.

Competitive Scenario:

Key players operating in the Global Breathing Disorders & Treatment Market include Philips Healthcare, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Medtronic plc, Drive DeVilbiss Healthcare, Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Invacare Corporation, Masimo Corporation, and Chart Industries.

These companies focus on product innovation, strategic partnerships, mergers & acquisitions, and expanding their product portfolios to strengthen their market position.

Scope of Work – Global Breathing Disorders & Treatment Market

Report Metric Details

Market Size (2023) USD 18.2 billion

Projected Market Size (2031) USD 31.7 billion

CAGR (2023-2031) 6.9%

Key Segments by System Type Therapeutic Devices, Monitoring Devices, Diagnostic Devices

Key Segments by End-use Hospitals & Clinics, Homecare Settings, Ambulatory Surgical Centers

Leading Region North America

Key Players Philips Healthcare, ResMed Inc., Fisher & Paykel Healthcare, Medtronic plc, Drive DeVilbiss Healthcare, Drägerwerk AG, Teleflex Inc., Invacare Corporation, Masimo Corporation, Chart Industries

Key Market Developments:

In 2023, Philips Healthcare launched a new line of connected CPAP and BiPAP devices for better remote patient monitoring.

ResMed Inc. announced the acquisition of a homecare respiratory device start-up in 2024 to enhance its home-based care solutions.

Fisher & Paykel Healthcare introduced advanced humidification technology in their respiratory therapy devices in 2025.

In 2023, Teleflex Incorporated expanded its range of minimally invasive ventilation products targeting sleep apnea patients.

FAQs:

1. What is the current market size of the Global Breathing Disorders & Treatment Market?

The Global Breathing Disorders & Treatment Market was valued at USD 18.2 billion in 2023.

2. What is the major growth driver of the Global Breathing Disorders & Treatment Market?

The increasing prevalence of respiratory diseases, technological advancements in treatment devices, and rising demand for home healthcare are key growth drivers.

3. Which is the largest region during the forecast period in the Global Breathing Disorders & Treatment Market?

North America is expected to dominate the market due to its advanced healthcare infrastructure and high disease prevalence.

4. Which segment accounted for the largest market share in the Global Breathing Disorders & Treatment Market?

The Therapeutic Devices segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Breathing Disorders & Treatment Market?

Key players include Philips Healthcare, ResMed Inc., Fisher & Paykel Healthcare, Medtronic plc, Drive DeVilbiss Healthcare, Drägerwerk AG, Teleflex Inc., Invacare Corporation, Masimo Corporation, and Chart Industries.